A vision for a healthier future

At NuMeRI, we are redefining nuclear medicine research by:

✓

fostering researcher collaboration to strengthen nuclear research capacity,

✓

promoting South African research in Medicinal Chemistry and Applied Biosciences,

✓

accelerating new product development for national priority diseases, e.g. Cancer, Tuberculosis, enabling new pharmaceuticals to reach market sooner, and giving South African pharmaceutical development a competitive edge with global equivalents. This can be achieved through fostering collaborative engagement with local similar industries.

✓

developing affordable generic drugs for third-world nations, and

✓

improving the quality of life of South Africans.

The NuMeRI team is combining their years of experience and passion for pushing the boundaries of nuclear medicine to guide NuMeRI in its vision for a healthier future

Learn More
NuMeRI Laboratory Facility

The Aim of NuMeRI

NuMeRI's effectiveness is measured in terms of how efficiently it provides access to researchers, which in turn will lead to research, innovation and value generation in areas of country- and region-specific health challenges. NuMeRI continues to be instrumental in capacitating the public healthcare sector with critical/scarce skilled medical professionals (nuclear medicine, medical physics, radiopharmacy, radiochemistry and radiobiology) through the provision of key infrastructure that is unique to their field(s).

  • Strengthen the Nuclear Medicine capacity in South Africa and beyond its borders in Africa.
  • Enhance South African research in Medicinal Chemistry.
  • Expedite development of drugs to address national priority diseases, e.g. Cancer, Tuberculosis, enabling new pharmaceuticals to reach market sooner, and giving South African pharmaceutical development a competitive edge with global equivalents. This can be achieved through fostering collaborative engagement with local similar industries.
  • Make generic drugs that are more affordable to developing nations;
  • Improve the quality of life of our local population via the "cells to community" and "community for cells" programs.
Learn More

Pre-Clinical Molecular Imaging Facility

A preclinical molecular imaging facility with unique scope to Southern Africa dedicated to drug development and translational research. It provides state-of-the-art in-vitro and in-vivo imaging services to South African researchers, clinicians, and pharmaceutical companies.

Learn More

Clinical and Theranostics

Our facility is equipped with the latest technology, and our team of experts is experienced in all aspects of clinical research. We are committed to providing the highest quality service to our clients and contributing to the advancement of medical science.

Learn More

Node for Infection Imaging

Our state-of-the-art facility is fully integrated into clinical research best practices, making us the most comprehensive medical imaging facility in Southern Africa dedicated to drug development and clinical research.

Learn More

Medical Physics and Radiobiology

Our state-of-the-art biocontainment facility is the perfect place to safely handle research and experiments involving hazard group three pathogens. Our facility is equipped with the latest safety technology, including negative pressure rooms and HEPA filters, to ensure that you can work with biohazardous materials.

Learn More

Radiopharmacy

We're dedicated to pushing the boundaries of research by creating and synthesising cutting-edge radiopharmaceuticals for diagnosing and treating infectious and non-communicable diseases in our radiopharmacy.

Learn More

Basic and Translational Research

NuMeRI Basic and Translational Research (BTR) seeks to translate discoveries acquired in the laboratory through bench-based analyses into real-world clinical practice directly benefiting human health and influencing policy.

Learn More